Past and future evolution in colloidal drug delivery systems. - Wikidata - awgldk - TriplyDB

Past and future evolution in colloidal drug delivery systems.

Past and future evolution in colloidal drug delivery systems.

http://www.wikidata.org/entity/Q37039030

about

Summary report of PQRI Workshop on Nanomaterial in Drug Products: current experience and management of potential risks.Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances.Standardization of models and methods used to assess nanoparticles in cardiovascular applications.Cholesterol--a biological compound as a building block in bionanotechnology.Economic and societal dimensions of nanotechnology-enabled drug delivery.Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines.Cellular Response to Linear and Branched Poly(acrylic acid).From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS).Fungi-assisted silver nanoparticle synthesis and their applications.Nano- and Microencapsulation of Vitamins

P2860

Q34871881-16EF24EE-3212-4E13-9BEA-5E560570C9CF Q37631874-FDE9416A-E5F3-4278-ABA9-0DADFE6AA0B8 Q37818332-B107C829-6207-4399-9C03-1AE1B17041A6 Q37841416-EF7A9A3C-94B2-4E96-97EB-5129F455D551 Q38061564-B68C10CD-E747-42FF-86E2-B4499C90C7BC Q38081220-2E37FDD6-AC88-46D4-94E1-5951F2CF230C Q38267521-D1529595-7E16-4421-A848-B9E21832ADC4 Q38844974-8F932B80-517E-4843-8569-7F22EA8B8054 Q38916539-67701D83-D222-4597-8188-4F6F772E2317 Q47614055-07181283-173B-463F-BB43-A539B5FCA4D0 Q58874329-80273110-7F32-4AFE-A529-40811C52CE2D

P2860

Past and future evolution in colloidal drug delivery systems.

http://www.wikidata.org/entity/Q37039030

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Past and future evolution in colloidal drug delivery systems.

@en

Past and future evolution in colloidal drug delivery systems.

@nl

type

label

Past and future evolution in colloidal drug delivery systems.

@en

Past and future evolution in colloidal drug delivery systems.

@nl

prefLabel

Past and future evolution in colloidal drug delivery systems.

@en

Past and future evolution in colloidal drug delivery systems.

@nl

P1433

Q37039030-2D83B5E7-49C5-46CA-A7F9-3CEF32A29B48

P1476

Q37039030-B0FFA587-0A6C-42E0-8B31-929EE502DFC0

P2093

Q37039030-A0D650D2-269F-4451-B7CF-006A2D9CE68F

P2860

Q37039030-004C4DD1-E85B-4FDE-9F7D-B3078AB6C7F8

Q37039030-09F6A8C5-8D78-4A3C-A46F-FECC5E917371

Q37039030-0C6C8FD8-4ED5-4E77-A05B-8CE5C42E6787

Q37039030-0C8A616E-DB46-4AEC-B262-A2A33772F594

Q37039030-0EFE20FB-EC17-4A7E-A4E8-A0196E40EBA9

Q37039030-1076B39E-CD76-482A-B9AB-3FFF9411AF79

Q37039030-11827B6E-97EB-4085-8016-41CD3AFF42B0

Q37039030-13EF2623-6168-4877-8528-38122BAC2296

Q37039030-1665F9E3-E5D7-4413-A0AE-96D727771D7D

Q37039030-1D59E765-73FD-4033-ADB5-CEB96FEB6A35

P304

Q37039030-677C8795-A095-417D-B985-2A7AB11003BC

P31

Q37039030-3EE25F10-D4E3-4D9E-BEA5-32D8079B2134

P356

Q37039030-FF1A394D-9BBF-493F-A4DE-1B0CC847A83C

P407

Q37039030-30078C32-F9D9-4ED3-85AB-A10E4708F802

P433

Q37039030-733C15B0-3A89-4D9F-8CD0-5D74612F1E77

P478

Q37039030-26AAC6EA-47A5-4C2E-A3E4-FF5C483AB5E5

P50

Q37039030-D1EB8195-A04C-4E6E-A4F1-46EB04254817

P577

Q37039030-79A97A40-7391-4411-93E9-4A48347C3ABC

P698

Q37039030-C21110BA-9A35-48AB-833E-04067813A0DB

P921

Q37039030-586D6987-4620-4B82-B329-57FD2E6E593E

P356

17425247.5.1.69

P1433

Expert Opinion on Drug Delivery

P1476

Past and future evolution in colloidal drug delivery systems

@en

P2093

Ben J Boyd

http://www.w3.org/2001/XMLSchema#string

P2860

Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles

Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers.

Synthesis and evaluation of novel dendrimers with a hydrophilic interior as nanocarriers for drug delivery.

Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells.

Biotin reagents for antibody pretargeting. 3. Synthesis, radioiodination, and evaluation of biotinylated starburst dendrimers.

Transferrin conjugates of doxorubicin: synthesis, characterization, cellular uptake, and in vitro efficacy.

Biological evaluation of polyester dendrimer: poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture.

Antithrombogenic properties of bioconjugate streptokinase-polyglycerol dendrimers.

New method for delivering a hydrophobic drug for photodynamic therapy using pure nanocrystal form of the drug.

Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery.

P304

69-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425247.5.1.69

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18095929

http://www.w3.org/2001/XMLSchema#string

P921